Back to first-pass browser

First-pass extracted concept

antibacterial nanoparticles

Candidate: concept label1 source documents5 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

nanoparticles, NPs

Extracted Explainers

What the tool is doing

This review describes nanoparticles as antibacterial agents used to target bacteria across coatings, wound-related materials, delivery systems, diagnostics, and vaccines.

Source 1DOIPubMed

What problem it solves

They are presented as an alternative to antibiotics for treating or preventing bacterial infections.

Source 1DOIPubMed

What it does not solve

The abstract indicates that the antibacterial mechanisms are still poorly understood, so mechanistic predictability remains limited.

Source 1DOIPubMed

Alternatives

The abstract explicitly contrasts nanoparticles with antibiotics by framing them as an alternative antibacterial approach.

Source 1DOIPubMed

Evidence Snippets

Nanoparticles (NPs) are increasingly used to target bacteria as an alternative to antibiotics.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1application scopesupports2017Source 1DOIPubMed

Antibacterial nanoparticles are increasingly used to target bacteria as an alternative to antibiotics.

Quoted textsource-backed
Nanoparticles (NPs) are increasingly used to target bacteria as an alternative to antibiotics.
Claim 2application scopesupports2017Source 1DOIPubMed

The review identifies antibacterial coatings, antibiotic delivery systems, bacterial detection systems, and antibacterial vaccines as application areas for nanoparticles.

Quoted textsource-backed
Examples include the utilization of NPs in antibacterial coatings for implantable devices and medicinal materials to prevent infection and promote wound healing, in antibiotic delivery systems to treat disease, in bacterial detection systems to generate microbial diagnostics, and in antibacterial vaccines to control bacterial infections.
Claim 3limitationsupports2017Source 1DOIPubMed

The antibacterial mechanisms of nanoparticles are poorly understood.

Quoted textsource-backed
The antibacterial mechanisms of NPs are poorly understood
Claim 4mechanism summarysupports2017Source 1DOIPubMed

The currently accepted antibacterial mechanisms of nanoparticles include oxidative stress induction, metal ion release, and non-oxidative mechanisms.

Quoted textsource-backed
The antibacterial mechanisms of NPs are poorly understood, but the currently accepted mechanisms include oxidative stress induction, metal ion release, and non-oxidative mechanisms.
Claim 5resistance rationalesupports2017Source 1DOIPubMed

Because nanoparticles can act through multiple simultaneous antimicrobial mechanisms, bacterial resistance to nanoparticles is described as difficult to develop.

Quoted textsource-backed
The multiple simultaneous mechanisms of action against microbes would require multiple simultaneous gene mutations in the same bacterial cell for antibacterial resistance to develop; therefore, it is difficult for bacterial cells to become resistant to NPs.